Merck & CompanyvsSTAAR Surgical

MRK and STAA stock compared: price, dividend, valuation and results, from SEC filings.

MRK

Merck & Company, Inc.

$143.37

Value $354B

-2.23%
MRK's page

Merck & Company (MRK) has a market value of $354B and STAAR Surgical (STAA) $1.3B. Over the last year, with dividends, MRK moved +60.0% and STAA -1.2%. The P/E is 144.5 for MRK and 2,387.8 for STAA. Dividend yield: MRK 2.37%, STAA none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    MRK$354B

    STAA$1.3B

    MRK is 280 times STAA

  • Revenue, 12 months

    MRK$67.4B

    STAA$328M

    MRK is 205 times STAA

  • Net income, 12 months

    MRK$2.5B

    STAA$530.0K

    MRK is 4,628 times STAA

  • Operating margin

    MRK–

    STAA0.2%

  • ROIC

    MRK3.9%

    STAA0.2%

    3.7 points apart

  • P/E

    MRK144.5

    STAA2,387.8

    STAA is 17 times MRK

  • Dividend yield

    MRK2.4%

    STAA0.0%

    2.4 points apart

  • 5-year return

    MRK+101.1%

    STAA-76.8%

    177.9 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

MRK+101.1%

STAA-76.8%

10020020222023202420252026
Returns by period
PeriodMRKWith dividendsSTAAWith dividends
1 year since November 14, 2025+60.0%Price +55.5%-1.2%Price -1.2%
3 years since November 16, 2023+55.2%+15.8% a yearPrice +41.6%-26.2%-9.6% a yearPrice -26.2%
5 years since November 15, 2021+101.1%+15.0% a yearPrice +72.6%-76.8%-25.3% a yearPrice -76.8%
10 years since November 17, 2016+227.6%+12.6% a yearPrice +141.5%+146.5%+9.4% a yearPrice +146.5%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

MRKMerck & CompanySTAASTAAR Surgical

Valuation

MRKSTAA
Valuation
Price$143.37$25.56
Market value$354B$1.3B
Enterprise value (EV)$399B$1.1B
P/E144.52,387.8
P/E, 5-year median14.8–
P/B7.93.4
EV/EBIT83.71,510.9
Free cash flow yield4.2%1.4%

Results and growth

MRKSTAA
Results and growth
Revenue, 12 months$67.4B$328M
Net income, 12 months$2.5B$530.0K
Free cash flow, 12 months$14.7B$18M
Earnings per share, 12 months$0.98$0.01
Revenue growth, year on year1.3%-23.7%
Revenue growth a year, past+9.4%over 5 years+7.9%over 5 years
EPS growth a year, past+21.2%over 5 years–

Margins and returns on capital

MRKSTAA
Margins and returns on capital
Gross margin71.8%73.6%
Operating margin–0.2%
Net margin3.6%0.2%
ROIC3.9%0.2%
ROE5.2%0.2%

Balance sheet

MRKSTAA
Balance sheet
Cash$9.7B$206M
Total debt$53.8B$34M
Net debt / EBITDA5.7-22.9
Interest cover2.4×–

Dividends and buybacks

MRKSTAA
Dividends and buybacks
Dividend yield2.4%–
Dividend per share, 12 months$3.40–
Dividend growth a year, past+5.8%over 5 years–
Buyback yield1.4%0.5%
Shareholder yield3.8%0.5%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: MRK or STAA

Didn't find what you were looking for?

Ask us
Which is bigger, Merck & Company or STAAR Surgical?

By market value, Merck & Company ($354B) is about 280.1 times STAAR Surgical ($1.3B), at today's prices.

How did MRK and STAA stock do over the last 10 years?

Since November 17, 2016, MRK's price moved +141.5% and STAA's +146.5%. With dividends: MRK +227.6% (+12.6% a year), STAA +146.5% (+9.4% a year). Past returns do not predict future ones.

Which pays the higher dividend, MRK or STAA?

The dividend yield at today's price is 2.37% for Merck & Company and none for STAAR Surgical. Over the last twelve months they paid $3.40 and – per share.

What is the P/E of MRK and STAA?

At today's price, the P/E is 144.5 for MRK and 2,387.8 for STAA. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Merck & Company or STAAR Surgical?

Over the last twelve months, the net margin was 3.6% for Merck & Company and 0.2% for STAAR Surgical, and the operating margin – and 0.2%. Revenue was $67.4B and $328M.

Which is the better investment, Merck & Company or STAAR Surgical?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.